Sumit Aggarwal
Chief Executive Officer, Eloxx Pharmaceuticals, Inc.
Companies
- Eloxx Pharmaceuticals, Inc.Board member Apr 2, 2021 to now1
- Eloxx Pharmaceuticals, Inc.Chief executive officer Apr 2, 2021 to now1
- Eloxx Pharmaceuticals, Inc.President Apr 2, 2021 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Eloxx Pharmaceuticals, Inc. ELOX1,672,756 shares2$21.8M at $13.03Feb 28, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 28, 2026Exercised options 260,946 shares at $0.15 of Eloxx Pharmaceuticals, Inc.2
- Jan 24, 2026Exercised options 15,000 shares of Eloxx Pharmaceuticals, Inc.2
- Sep 19, 2025Granted 1,000,000 shares of Eloxx Pharmaceuticals, Inc.2
- Aug 14, 2025Exercised options 196,880 shares of Eloxx Pharmaceuticals, Inc.2
- Jan 24, 2025Exercised options 30,000 shares of Eloxx Pharmaceuticals, Inc.3
- Oct 16, 2024Granted 165,000 shares of Eloxx Pharmaceuticals, Inc.4
- Dec 1, 2021Shares withheld for tax 81,933 shares at $0.72 of Eloxx Pharmaceuticals, Inc.5
- Dec 1, 2021Exercised options 279,158 shares of Eloxx Pharmaceuticals, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jan 28, 2025
- 4SEC EDGARForm 4 filed Oct 17, 2024
- 5SEC EDGARForm 4 filed Dec 3, 2021